Comparing reduced port laparoscopic gastrectomy to traditional methods for gastric cancer
Official title: Comparison the Short and Long-term Outcome of Patients With Gastric Cancer Who Underwent Reduced Port Laparoscopic Gastrectomy With Patients Underwent Traditional Laparoscopic Gastrectomy
Run by Nanchong Central Hospital · NCT04295473 · Data updated 2026-11-12
This study tests if a new way of doing stomach surgery with fewer small cuts is safer and works better for people with gastric cancer compared to the usual method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Nanchong Central Hospital Government |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Nanchong, Sichuan) |
| Status | Recruiting |
| Started | March 2, 2020 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | May 21, 2025 |
| Trial ID | NCT04295473 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with histologically confirmed adenocarcinoma of the stomach at stages T1-T4 and an Eastern Cooperative Oncology Group performance status of 0 or 1.
✕Probably not a fit
Patients with distant metastasis, significant oesophageal invasion, or those who have received prior chemotherapy or radiation therapy for other malignancies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and outcomes of reduced port laparoscopic gastrectomy in patients with gastric cancer compared to traditional laparoscopic gastrectomy. It aims to assess both short-term outcomes, such as surgical complications and postoperative nutrition, and long-term outcomes, including survival rates. The study involves patients with histologically confirmed adenocarcinoma of the stomach and will systematically analyze the results to determine the effectiveness of the reduced port approach.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients undergoing gastrectomy for gastric cancer.
How similar studies have gone: While reduced port laparoscopic techniques are gaining traction, systematic evaluations comparing them to traditional methods are still limited, making this study a potentially novel contribution.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages. 2. Eastern Cooperative Oncology Group performance status of 0 or 1. 3. Adequate organ function. Exclusion Criteria: 1. Patients had distant metastasis. 2. oesophageal invasion of more than 3 cm. 3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma. 4. Previous chemotherapy or radiation therapy for any other malignancies.
Where it's running
-
Yunhong Tian
Nanchong, Sichuan, China Recruiting
Study contacts
- Principal investigator: Yunhong Tian, MD — Nanchong Central Hospital
- Study coordinator: Yunhong Tian, MD
- Email: drtianyunhong@126.com
- Phone: +86-13508087719
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing two methods of ondansetron administration for pain relief after weight loss surgery
This study is testing whether giving ondansetron through a nerve block can help reduce pain and nausea after weight loss surgery just as well as the traditional intravenous method.
-
Laparoscopy vs Open Surgery for Endometrial Cancer Staging in Low-Resource Settings
This study tests whether laparoscopic surgical staging for early endometrial cancer leads to faster first ambulation compared with open surgery in low-resource settings.
-
International registry of robot-assisted minimally invasive surgery for gastric cancer
This registry will collect information to see how robot-assisted minimally invasive gastrectomy (RAMIG) works and how surgeons learn it for people having surgery for gastric cancer.
-
Anrikefon Injection for Postoperative Pain After Laparoscopic Gastrectomy in Gastric Cancer
This trial tests whether Anrikefon given by IV can reduce pain after totally laparoscopic distal gastrectomy for gastric cancer.
-
Lower versus standard abdominal gas pressure to reduce shoulder pain after gynecologic laparoscopy
This trial will test whether using lower gas pressure (10 mm Hg) instead of standard pressure (15 mm Hg) during benign gynecologic laparoscopic surgery reduces shoulder-tip pain afterwards.
-
Evaluating NORTASE® for patients after stomach surgery
This study tests if taking NORTASE®, an enzyme supplement, can help improve the quality of life and weight for patients after stomach surgery compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.